A novel graphene oxide–niclosamide hybrid as a potent antiviral agent against dengue virus serotype 3
- 22 November 2025
- journal article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 259, 115304
Abstract
No abstract availableKeywords
Funding Information
- Chiba University
- Kementerian Riset, Teknologi dan Pendidikan Tinggi (2077/UN1/DITLIT/PT.01.03/2024)
This publication has 44 references indexed in Scilit:
- Evaluation of the catalytic and antioxidant activity of in situ green synthesized graphene-gold nanocompositeCarbon Letters, 2024
- Injectable immunomodulation-based porous chitosan microspheres/HPCH hydrogel composites as a controlled drug delivery system for osteochondral regenerationBiomaterials, 2022
- Unveiling bonding states and roles of edges in nitrogen-doped graphene nanoribbon by X-ray photoelectron spectroscopyCarbon, 2021
- Unlocking thermogravimetric analysis (TGA) in the fight against “Fake graphene” materialsCarbon, 2021
- Size-dependent aggregation of graphene oxideCarbon, 2020
- Dengue viruses circulating in Indonesia: A systematic review and phylogenetic analysis of data from five decadesReviews in Medical Virology, 2019
- Progress of reduction of graphene oxide by ascorbic acidApplied Surface Science, 2018
- Niclosamide: Beyond an antihelminthic drugCellular Signalling, 2018
- Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrierBiomaterials, 2014
- In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administrationBiomaterials, 2013